PATZ1 and astroblastoma: This was exemplified in our patient with an MN1 fusion-positive astroblastoma (P2058), where global methylation profiling was uninformative, and targeted MN1 testing would have missed the second gene fusion detected, EWSR1-PATZ1 [14].